aluates Reports

$ 0.0

Automative

Global Human Bacterial Vaccine Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-4C10441

Global Human Bacterial Vaccine Market Insights Forecast to 2028

BUY CHAPTERS

Global Human Bacterial Vaccine Market Research Report 2025

Code: QYRE-Auto-4C10441

Report

July 2025

Pages:75

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Merck

Sanofi

GSK

Mitsubishi Tanabe Pharma

Pfizer Inc

Bayer

Emergent Biosolutions

Human Bacterial Vaccine Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Human Bacterial Vaccine Market

The global market for Human Bacterial Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Human Bacterial Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Bacterial Vaccine.

The Human Bacterial Vaccine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Bacterial Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Bacterial Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Human Bacterial Vaccine Market Report

Report Metric	Details
Report Name	Human Bacterial Vaccine Market
CAGR	5%
Segment by Type	Clostridium Tetani Pertussis Haemophilus Influenzae Streptococcus Pneumoniae Salmonella Typhi Bacillus Anthracis Others
Segment by Application	Children Adults Elderly
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, Sanofi, GSK, Mitsubishi Tanabe Pharma, Pfizer, Bayer, Emergent BioSolutions
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Bacterial Vaccine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Human Bacterial Vaccine Market report?

Ans: The main players in the Human Bacterial Vaccine Market are Merck, Sanofi, GSK, Mitsubishi Tanabe Pharma, Pfizer, Bayer, Emergent BioSolutions

What are the Application segmentation covered in the Human Bacterial Vaccine Market report?

Ans: The Applications covered in the Human Bacterial Vaccine Market report are Children, Adults, Elderly

What are the Type segmentation covered in the Human Bacterial Vaccine Market report?

Ans: The Types covered in the Human Bacterial Vaccine Market report are Clostridium Tetani, Pertussis, Haemophilus Influenzae, Streptococcus Pneumoniae, Salmonella Typhi, Bacillus Anthracis, Others

Recommended Reports

Bacterial & Viral Vaccines

Vaccine Technology & Trends

Vaccine Delivery Solutions

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Human Bacterial Vaccine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Clostridium Tetani

1.2.3 Pertussis

1.2.4 Haemophilus Influenzae

1.2.5 Streptococcus Pneumoniae

1.2.6 Salmonella Typhi

1.2.7 Bacillus Anthracis

1.2.8 Others

1.3 Market by Application

1.3.1 Global Human Bacterial Vaccine Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Children

1.3.3 Adults

1.3.4 Elderly

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Human Bacterial Vaccine Market Perspective (2020-2031)

2.2 Global Human Bacterial Vaccine Growth Trends by Region

2.2.1 Global Human Bacterial Vaccine Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Human Bacterial Vaccine Historic Market Size by Region (2020-2025)

2.2.3 Human Bacterial Vaccine Forecasted Market Size by Region (2026-2031)

2.3 Human Bacterial Vaccine Market Dynamics

2.3.1 Human Bacterial Vaccine Industry Trends

2.3.2 Human Bacterial Vaccine Market Drivers

2.3.3 Human Bacterial Vaccine Market Challenges

2.3.4 Human Bacterial Vaccine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Human Bacterial Vaccine Players by Revenue

3.1.1 Global Top Human Bacterial Vaccine Players by Revenue (2020-2025)

3.1.2 Global Human Bacterial Vaccine Revenue Market Share by Players (2020-2025)

3.2 Global Human Bacterial Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Human Bacterial Vaccine Revenue

3.4 Global Human Bacterial Vaccine Market Concentration Ratio

3.4.1 Global Human Bacterial Vaccine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Human Bacterial Vaccine Revenue in 2024

3.5 Global Key Players of Human Bacterial Vaccine Head office and Area Served

3.6 Global Key Players of Human Bacterial Vaccine, Product and Application

3.7 Global Key Players of Human Bacterial Vaccine, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Human Bacterial Vaccine Breakdown Data by Type

4.1 Global Human Bacterial Vaccine Historic Market Size by Type (2020-2025)

4.2 Global Human Bacterial Vaccine Forecasted Market Size by Type (2026-2031)

5 Human Bacterial Vaccine Breakdown Data by Application

5.1 Global Human Bacterial Vaccine Historic Market Size by Application (2020-2025)

5.2 Global Human Bacterial Vaccine Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Human Bacterial Vaccine Market Size (2020-2031)

6.2 North America Human Bacterial Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Human Bacterial Vaccine Market Size by Country (2020-2025)

6.4 North America Human Bacterial Vaccine Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Human Bacterial Vaccine Market Size (2020-2031)

7.2 Europe Human Bacterial Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Human Bacterial Vaccine Market Size by Country (2020-2025)

7.4 Europe Human Bacterial Vaccine Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Human Bacterial Vaccine Market Size (2020-2031)

8.2 Asia-Pacific Human Bacterial Vaccine Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Human Bacterial Vaccine Market Size by Region (2020-2025)

8.4 Asia-Pacific Human Bacterial Vaccine Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Human Bacterial Vaccine Market Size (2020-2031)

9.2 Latin America Human Bacterial Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Human Bacterial Vaccine Market Size by Country (2020-2025)

9.4 Latin America Human Bacterial Vaccine Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Human Bacterial Vaccine Market Size (2020-2031)

10.2 Middle East & Africa Human Bacterial Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Human Bacterial Vaccine Market Size by Country (2020-2025)

10.4 Middle East & Africa Human Bacterial Vaccine Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck

11.1.1 Merck Company Details

11.1.2 Merck Business Overview

11.1.3 Merck Human Bacterial Vaccine Introduction

11.1.4 Merck Revenue in Human Bacterial Vaccine Business (2020-2025)

11.1.5 Merck Recent Development

11.2 Sanofi

11.2.1 Sanofi Company Details

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Human Bacterial Vaccine Introduction

11.2.4 Sanofi Revenue in Human Bacterial Vaccine Business (2020-2025)

11.2.5 Sanofi Recent Development

11.3 GSK

11.3.1 GSK Company Details

11.3.2 GSK Business Overview

11.3.3 GSK Human Bacterial Vaccine Introduction

11.3.4 GSK Revenue in Human Bacterial Vaccine Business (2020-2025)

11.3.5 GSK Recent Development

11.4 Mitsubishi Tanabe Pharma

11.4.1 Mitsubishi Tanabe Pharma Company Details

11.4.2 Mitsubishi Tanabe Pharma Business Overview

11.4.3 Mitsubishi Tanabe Pharma Human Bacterial Vaccine Introduction

11.4.4 Mitsubishi Tanabe Pharma Revenue in Human Bacterial Vaccine Business (2020-2025)

11.4.5 Mitsubishi Tanabe Pharma Recent Development

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Human Bacterial Vaccine Introduction

11.5.4 Pfizer Revenue in Human Bacterial Vaccine Business (2020-2025)

11.5.5 Pfizer Recent Development

11.6 Bayer

11.6.1 Bayer Company Details

11.6.2 Bayer Business Overview

11.6.3 Bayer Human Bacterial Vaccine Introduction

11.6.4 Bayer Revenue in Human Bacterial Vaccine Business (2020-2025)

11.6.5 Bayer Recent Development

11.7 Emergent BioSolutions

11.7.1 Emergent BioSolutions Company Details

11.7.2 Emergent BioSolutions Business Overview

11.7.3 Emergent BioSolutions Human Bacterial Vaccine Introduction

11.7.4 Emergent BioSolutions Revenue in Human Bacterial Vaccine Business (2020-2025)

11.7.5 Emergent BioSolutions Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Merck

Sanofi

GSK

Mitsubishi Tanabe Pharma

Pfizer Inc

Bayer

Emergent Biosolutions

List of Tables

Table 1. Global Human Bacterial Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Clostridium Tetani

Table 3. Key Players of Pertussis

Table 4. Key Players of Haemophilus Influenzae

Table 5. Key Players of Streptococcus Pneumoniae

Table 6. Key Players of Salmonella Typhi

Table 7. Key Players of Bacillus Anthracis

Table 8. Key Players of Others

Table 9. Global Human Bacterial Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Human Bacterial Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Human Bacterial Vaccine Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Human Bacterial Vaccine Market Share by Region (2020-2025)

Table 13. Global Human Bacterial Vaccine Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Human Bacterial Vaccine Market Share by Region (2026-2031)

Table 15. Human Bacterial Vaccine Market Trends

Table 16. Human Bacterial Vaccine Market Drivers

Table 17. Human Bacterial Vaccine Market Challenges

Table 18. Human Bacterial Vaccine Market Restraints

Table 19. Global Human Bacterial Vaccine Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Human Bacterial Vaccine Market Share by Players (2020-2025)

Table 21. Global Top Human Bacterial Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Bacterial Vaccine as of 2024)

Table 22. Ranking of Global Top Human Bacterial Vaccine Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Human Bacterial Vaccine Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Human Bacterial Vaccine, Headquarters and Area Served

Table 25. Global Key Players of Human Bacterial Vaccine, Product and Application

Table 26. Global Key Players of Human Bacterial Vaccine, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Human Bacterial Vaccine Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Human Bacterial Vaccine Revenue Market Share by Type (2020-2025)

Table 30. Global Human Bacterial Vaccine Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Human Bacterial Vaccine Revenue Market Share by Type (2026-2031)

Table 32. Global Human Bacterial Vaccine Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Human Bacterial Vaccine Revenue Market Share by Application (2020-2025)

Table 34. Global Human Bacterial Vaccine Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Human Bacterial Vaccine Revenue Market Share by Application (2026-2031)

Table 36. North America Human Bacterial Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Human Bacterial Vaccine Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Human Bacterial Vaccine Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Human Bacterial Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Human Bacterial Vaccine Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Human Bacterial Vaccine Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Human Bacterial Vaccine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Human Bacterial Vaccine Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Human Bacterial Vaccine Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Human Bacterial Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Human Bacterial Vaccine Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Human Bacterial Vaccine Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Human Bacterial Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Human Bacterial Vaccine Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Human Bacterial Vaccine Market Size by Country (2026-2031) & (US$ Million)

Table 51. Merck Company Details

Table 52. Merck Business Overview

Table 53. Merck Human Bacterial Vaccine Product

Table 54. Merck Revenue in Human Bacterial Vaccine Business (2020-2025) & (US$ Million)

Table 55. Merck Recent Development

Table 56. Sanofi Company Details

Table 57. Sanofi Business Overview

Table 58. Sanofi Human Bacterial Vaccine Product

Table 59. Sanofi Revenue in Human Bacterial Vaccine Business (2020-2025) & (US$ Million)

Table 60. Sanofi Recent Development

Table 61. GSK Company Details

Table 62. GSK Business Overview

Table 63. GSK Human Bacterial Vaccine Product

Table 64. GSK Revenue in Human Bacterial Vaccine Business (2020-2025) & (US$ Million)

Table 65. GSK Recent Development

Table 66. Mitsubishi Tanabe Pharma Company Details

Table 67. Mitsubishi Tanabe Pharma Business Overview

Table 68. Mitsubishi Tanabe Pharma Human Bacterial Vaccine Product

Table 69. Mitsubishi Tanabe Pharma Revenue in Human Bacterial Vaccine Business (2020-2025) & (US$ Million)

Table 70. Mitsubishi Tanabe Pharma Recent Development

Table 71. Pfizer Company Details

Table 72. Pfizer Business Overview

Table 73. Pfizer Human Bacterial Vaccine Product

Table 74. Pfizer Revenue in Human Bacterial Vaccine Business (2020-2025) & (US$ Million)

Table 75. Pfizer Recent Development

Table 76. Bayer Company Details

Table 77. Bayer Business Overview

Table 78. Bayer Human Bacterial Vaccine Product

Table 79. Bayer Revenue in Human Bacterial Vaccine Business (2020-2025) & (US$ Million)

Table 80. Bayer Recent Development

Table 81. Emergent BioSolutions Company Details

Table 82. Emergent BioSolutions Business Overview

Table 83. Emergent BioSolutions Human Bacterial Vaccine Product

Table 84. Emergent BioSolutions Revenue in Human Bacterial Vaccine Business (2020-2025) & (US$ Million)

Table 85. Emergent BioSolutions Recent Development

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

Table 89. Authors List of This Report

List of Figures

Figure 1. Human Bacterial Vaccine Picture

Figure 2. Global Human Bacterial Vaccine Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Human Bacterial Vaccine Market Share by Type: 2024 VS 2031

Figure 4. Clostridium Tetani Features

Figure 5. Pertussis Features

Figure 6. Haemophilus Influenzae Features

Figure 7. Streptococcus Pneumoniae Features

Figure 8. Salmonella Typhi Features

Figure 9. Bacillus Anthracis Features

Figure 10. Others Features

Figure 11. Global Human Bacterial Vaccine Market Size by Application (2020-2031) & (US$ Million)

Figure 12. Global Human Bacterial Vaccine Market Share by Application: 2024 VS 2031

Figure 13. Children Case Studies

Figure 14. Adults Case Studies

Figure 15. Elderly Case Studies

Figure 16. Human Bacterial Vaccine Report Years Considered

Figure 17. Global Human Bacterial Vaccine Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Human Bacterial Vaccine Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Human Bacterial Vaccine Market Share by Region: 2024 VS 2031

Figure 20. Global Human Bacterial Vaccine Market Share by Players in 2024

Figure 21. Global Top Human Bacterial Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Bacterial Vaccine as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Human Bacterial Vaccine Revenue in 2024

Figure 23. North America Human Bacterial Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Human Bacterial Vaccine Market Share by Country (2020-2031)

Figure 25. United States Human Bacterial Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Human Bacterial Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Human Bacterial Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Human Bacterial Vaccine Market Share by Country (2020-2031)

Figure 29. Germany Human Bacterial Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Human Bacterial Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Human Bacterial Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Human Bacterial Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Human Bacterial Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Human Bacterial Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Human Bacterial Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Human Bacterial Vaccine Market Share by Region (2020-2031)

Figure 37. China Human Bacterial Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Human Bacterial Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Human Bacterial Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Human Bacterial Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Human Bacterial Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Human Bacterial Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Human Bacterial Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Human Bacterial Vaccine Market Share by Country (2020-2031)

Figure 45. Mexico Human Bacterial Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Human Bacterial Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Human Bacterial Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Human Bacterial Vaccine Market Share by Country (2020-2031)

Figure 49. Turkey Human Bacterial Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Human Bacterial Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Human Bacterial Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Merck Revenue Growth Rate in Human Bacterial Vaccine Business (2020-2025)

Figure 53. Sanofi Revenue Growth Rate in Human Bacterial Vaccine Business (2020-2025)

Figure 54. GSK Revenue Growth Rate in Human Bacterial Vaccine Business (2020-2025)

Figure 55. Mitsubishi Tanabe Pharma Revenue Growth Rate in Human Bacterial Vaccine Business (2020-2025)

Figure 56. Pfizer Revenue Growth Rate in Human Bacterial Vaccine Business (2020-2025)

Figure 57. Bayer Revenue Growth Rate in Human Bacterial Vaccine Business (2020-2025)

Figure 58. Emergent BioSolutions Revenue Growth Rate in Human Bacterial Vaccine Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Human Genetically Engineered Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Influenza A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Tuberculosis Vaccine Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Ampoules Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Combinations Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Preventable Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Therapeutic BCG Vaccines Market Insights Forecast to 2030

Clostridium Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Bottle Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Administration Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

mRNA Vaccines for Infectious Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Plant based Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Shippers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Livestock Vaccine Market Research Report 2025

Pediatric Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prostate Cancer Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pneumococcal Conjugate Vaccine PCV Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions